FindMyKOL
Clinical trialNCT01826825CompletedObservational

Preoperative Cognitive Screening of Elderly Surgical Patients

NCT01826825 is an observational study sponsored by Brigham and Women's Hospital. As of 18 Nov 2026, it is completed. It studies Cognitive Impairment. The registry lists an enrollment of 200 participants at 1 site in 1 country. The registry lists a start date of 31 May 2013 and a primary completion date of 31 Oct 2013.

SponsorBrigham and Women's Hospital →Enrollment200Cognitive Impairment
View the registry record on ClinicalTrials.gov

Key facts

Registry attributes as recorded on the ClinicalTrials.gov study record.

Key facts for NCT01826825
FieldValue
Registry IDNCT01826825
StatusCompleted
Study typeObservational study
Lead sponsorBrigham and Women's Hospital
Enrollment200
Registered sites1
Countries1
ConditionsCognitive Impairment
Start31 May 2013
Primary completion31 Oct 2013
Study completion31 Aug 2015
Last update posted14 Apr 2021

Registered summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The objectives of this pilot study are: 1. to determine whether a short cognitive test battery administered in the preadmission test center can be used to cognitively stratify elderly patients presenting for elective surgical procedures. 2. to evaluate the cost of cognitive screening in the preoperative testing center in terms of time and finances. 3. to evaluate patient perceptions about the use of preoperative cognitive screening and their outcome expectations from their surgical procedure. Subsequent investigations may evaluate whether preoperative cognitive screening is a predictor of postoperative morbidity and mortality in elderly surgical patients and whether a short cognitive screen administered in the preadmission testing center could be used to identify individuals with baseline cognitive impairments that should be refered for more formal cognitive evaluation.

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Massachusetts, United States1 site
  • Brigham and Women's Hospital

    Boston

United States, by state

AlaskaAKMaineMEVermontVTNew HampshireNHWashingtonWAMontanaMTNorth DakotaNDMinnesotaMNWisconsinWIMichiganMINew YorkNYMassachusetts: 1 siteMA1Rhode IslandRIOregonORIdahoIDSouth DakotaSDIowaIAIllinoisILIndianaINOhioOHPennsylvaniaPANew JerseyNJConnecticutCTCaliforniaCANevadaNVWyomingWYNebraskaNEMissouriMOKentuckyKYWest VirginiaWVVirginiaVAMarylandMDDelawareDEArizonaAZUtahUTColoradoCOKansasKSArkansasARTennesseeTNNorth CarolinaNCSouth CarolinaSCNew MexicoNMOklahomaOKLouisianaLAMississippiMSAlabamaALGeorgiaGAHawaiiHITexasTXFloridaFLDistrict of ColumbiaDC
Fewer sitesMore sites

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Questions about NCT01826825

Each answer restates registry values shown on this page.

What is NCT01826825?

NCT01826825 is an observational study sponsored by Brigham and Women's Hospital. It studies Cognitive Impairment.

Who leads NCT01826825?

The registry names Angela Bader, MD, MPH (study chair, Brigham and Women's Hospital), Deborah J Culley, MD (principal investigator, Brigham Hospital), Devon M Flaherty, MD, MPH (study director, Brigham and Women's Hospital) and 1 more official as overall officials.

Where does NCT01826825 run?

The registry lists 1 site in 1 country. Every site with a stated country is in one country: United States.

When did NCT01826825 end?

The registry lists a primary completion date of 31 Oct 2013 and a study completion date of 31 Aug 2015. The sponsor last updated the record on 14 Apr 2021.

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 18 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.